The European Commission has reopened its call for healthcare organisations to join the European Network of AI-Powered Advanced Screening Centres, a flagship of the Apply AI Strategy expected to cover all EU Member States by the end of 2029.

Joining the Network offers organisations the opportunity to become part of a growing European community dedicated to ensuring the safe, effective and trustworthy use of artificial intelligence in healthcare. Centres can participate in piloting AI solutions in clinical environments and collaborative studies on AI performance.

270 healthcare organisations have already joined the Network in the first call.

If your institution has not yet become a member, there is still time to express your interest and apply!

 Click to apply by 10 September!

  Click to find more information! Please note at the bottom the list of benefits for centres and link to the terms of reference.

This is an excellent opportunity for hospitals, research institutions, screening centres and healthcare organisations across Europe to contribute to the future of innovative healthcare and collaborate with peers at the European level.

The European Institute for Biomedical Imaging Research (EIBIR) is pleased to host dedicated booth sessions at the European Congress of Radiology (ECR) 2027 in Vienna/Austria on 3-7 March 2027, showcasing cutting-edge research in biomedical imaging.

These booth sessions will feature oral poster presentations selected from submissions to the EIBIR category*, offering researchers a unique platform to present and discuss their work. This will provide the presenters with another opportunity to increase the visibility of their work in the EIBIR research community and the biomedical imaging landscape.

Poster submissions are invited to the following EIBIR topics:

• AI in Radiology (AI, oncologic, cardiovascular and neuro-imaging)
• Emerging technologies
• Hybrid imaging in oncology and cardiovascular disease
• Integrated diagnostics
• Multidisciplinary research and collaboration

All submitted posters undergo a thorough review process by esteemed members of the EIBIR Scientific Advisory Board, ensuring that high-quality, impactful research is presented. Selected authors will have the opportunity to deliver a short oral presentation of their poster at the EIBIR booth during ECR 2027, providing greater visibility and engagement with the ECR audience. Selected authors will be informed in due time about their participation. The best poster will also be awarded with the EIBIR Poster Award.

We encourage all researchers to submit their work for EIBIR Booth Sessions and to take part in this exciting opportunity at ECR 2027.

Join us to explore innovative projects and connect with leading experts in the field.

Abstract submission will run from 3 August to 30 September 2026.

Authors submitting an abstract for the EIBIR Booth Sessions are kindly requested to follow the submission steps below:

1. Under Preferred Presentation Format, please select Poster Presentation.
2. Under Poster Presentation Format, choose EIBIR Booth Session.
3. Finally, select the relevant topic from the list provided above under Topic.

To submit your poster abstract, click here.

If you have any questions on the EIBIR Booth Sessions, please contact the EIBIR team at office@eibir.org.

Due to popular demand, we are opening the CARE Study workshop for online participation!

European Commission SAMIRA Study Workshop on updated criteria for acceptability of medical radiological equipment – The workshop aims to present our proposal for an updated and extended list of acceptability criteria and to further consult with Member States and other stakeholders on the proposed document to be published in the European Commission’s Radiation Protection Series. The consortium combines experts from EIBIR, EFOMP, EANM and ESR.

Workshop dates: 1 June (13:00-18:00 CEST) – 2 June (09:00-16:00 CEST)

Study information and workshop programme: link

Participation is free of charge. Registration required 

We are happy to be sharing with you dedicated sessions and other activities hosted by EIBIR at the European Congress of Radiology (ECR) 2026, taking place from March 4–8, 2026, in Vienna and online via ESR Connect. This year’s congress is also a special milestone for EIBIR, as we celebrate our 20th anniversary! (See EIBIR Studio Sessions below)

EIBIR Sessions

EIBIR 4a – Novel approaches for trustworthy artificial intelligence (AI) in cancer diagnostics and treatment
Wednesday, March 4, 2026 | 13:00–14:30 | Room 01
Explore pioneering AI research from RadioVal, ODELIA, BreastSCan, and COMPASS-AI, focusing on ethical, explainable, and validated AI applications for cancer care.

EIBIR 6 – Assistive technologies for interventional radiologists: enhancing decision-making and workflow with AI-powered solutions
Wednesday, March 4, 2026 | 16:30–17:30 | Room 01
Find out how the SHERPA project is developing human-centred, AI-powered tools to support interventional radiologists, improving workflow, precision, and clinical outcomes.

EIBIR 8 – Transforming cardiovascular risk prediction with AI: from models to real-world impact
Thursday, March 5, 2026 | 10:00–11:00 | Room 01
Learn how the AI-POD project is advancing AI-driven cardiovascular risk prediction, combining clinical insight, ethical perspectives, and real-world validation to bring AI from research to practice.

HOW 8 – How we do it: clinical audit
Thursday, March 5, 2026 | 10:00–11:00 | Open Forum 1
A special presentation of the CLAUD-IT project, engage with some of Europe’s leading experts on clinical audit for a discussion of the project’s methodology and guidance for implementation with an aim for improved procedures and broader adoption in clinical practice.

EIBIR 11 – Cancer Image Europe: a pan-European federated infrastructure for cancer images
Thursday, March 5, 2026 | 16:30–18:00 | Room 01
Discover the latest developments from EUCAIM and the Cancer Image Europe platform, including progress towards establishing a European Digital Infrastructure Consortium (EDIC) for cancer imaging data sharing and AI development.

EIBIR 13 – Strengthening the screening of lung cancer in Europe: key achievements, lessons learned, and legacy of the SOLACE project
Friday, March 6, 2026 | 09:30–11:00 | Room 01
Learn how the SOLACE project is shaping the future of lung cancer screening across Europe, breaking down barriers to access and ensuring sustainability and equity in early detection.

EIBIR 15 – Advancements in medical imaging technologies: photonics research
Friday, March 6, 2026 | 13:45–14:45 | Audio Streaming Area
Discover breakthrough innovations from the HyperProbe and Med-IPUT projects, showcasing photonics-based imaging for neurosurgery and medical ultrasound, revolutionising precision imaging technologies.

EIBIR 16 – Improving quality and safety through collaborative EU-funded research and studies: the SAMIRA initiative
Friday, March 6, 2026 | 16:00–17:30 | Room 01
In collaboration with the European Commission and EuroSafe Imaging, this session highlights projects including RHYTHM, MARLIN, CARE, CLAUD-IT, and others driving excellence in radiation protection, safety, and quality assurance across Europe.

EIBIR Booth Sessions (onsite only, Austria Center level 1)

EIBIR IHI – IHI in a nutshell: a public–private research partnership for health
Wednesday, March 4, 2026 | 14:00–15:00
Insights into IHI’s public‑private research projects advancing innovative solutions to Europe’s key health challenges.

EIBIR/ESR – ESR Research Seed Grant global session
Friday, March 6, 2026 | 10:15–11:15
Multiple speaker session exploring pilot projects on sustainable, AI‑enhanced radiology from Egypt, Nigeria and Ghana.

EIBIR 1 – EIBIR Stage bonus session 1
Wednesday, March 4, 2026 | 11:30–12:30
Multiple speaker session exploring multidisciplinary research and collaboration.

EIBIR 2 – EIBIR Stage bonus session 2
Thursday, March 5, 2026 | 11:30–12:30
Multiple speaker session exploring hybrid imaging in oncology, emerging technologies, and multidisciplinary research and collaboration.

EIBIR 3 – EIBIR Stage bonus session 3
Thursday, March 5, 2026 | 15:00–16:00
Multiple speaker session exploring AI in oncology.

EIBIR 4b – EIBIR Stage bonus session 4
Friday, March 6, 2026 | 14:00–15:00
Multiple speaker session exploring AI in oncology.

EIBIR Studio Sessions (online only, open access)

ST 3 – Building the future of Cancer AI: Data, platform, and practice
Wednesday, March 4, 2026 | 9:30–10:00 | Studio Streaming Area
Dive into a session with EUCAIM, BreastSCan, and COMPASS-AI, three EU-funded projects defining the strategic European roadmap for AI in cancer imaging.

ST 4 – Celebrating 20 Years of EIBIR: Insights from Prof. Regina Beets-Tan
Wednesday, March 4, 2026 | 12:30–13:00 | Studio Streaming Area
Join us to  celebrate EIBIR’s 20th anniversary and the institute’s achievements in EU-funded biomedical imaging research, plus a presentation of EIBIR’s new Strategic Research Agenda!

ST 14 – The European Lung Cancer Screening Alliance (ELCSA): ensuring continuity and impact beyond SOLACE
Thursday, March 5, 2026 | 15:30–16:00 | Studio Streaming Area
Explore how SOLACE and the newly formed ELCSA are driving a Europe‑wide push for equitable, accessible lung cancer screening for all.

EUCAIM Demonstration Sessions (onsite only, Austria Center level 1)

DS 1 – From raw images to research‑ready data: tools and workflow for cancer imaging
Thursday, March 5, 2026 | 13:45
Join us for a great EUCAIM demonstration session with Carina Soler, covering everything from data preparation steps: original data context, image annotation, de-identification, data quality checks, ETL processes, and data transfer.

DS 2 – Sovereign image data sharing with EUCAIM: build your node
Friday, March 6, 2026 | 11:45
In this demonstration from Ignacio Blanquer, you will gather information on the type of tools for configuring a federated node that allows data sharing within the EUCAIM federation. You will also learn more about the intrinsic characteristics and capabilities of a EUCAIM federated node, and how to scale it into a powerful processing node.

Pixel Pandemonium

March 4–7, 2026 | 10:00–17:00 | Foyer K
This exhibit, organised by the ESR and EIBIR and endorsed by MICCAI, offers interactive software demonstrations for showcasing the latest AI and machine-learning tools in the field of medical imaging that will shape the future of healthcare. Demos in the exhibition include 15 software tools showcasing cutting-edge AI technology.

Visit us any time at the EIBIR booth!

The EIBIR booth on Level 1 will showcase the latest results from our EU-funded research projects and highlighting opportunities for collaboration and funding in biomedical imaging.

Join us at ECR 2026 to engage with Europe’s leading experts in imaging research and innovation — and to see how EIBIR-supported projects continue to shape the future of medical imaging!

Europe’s Beating Cancer Plan set out an ambitious agenda covering the entire cancer care continuum, including prevention, early detection, diagnosis, treatment, quality of life, survivorship, as well as research and innovation.

Five years after its launch, it is time to take stock of the progress achieved so far.

In this context, Vlad Voiculescu, rapporteur of the European Parliament for the Cancer Plan report, invites healthcare professionals, patients and carers, researchers, and decision-makers to share their views on:

• the impact of measures, initiatives, or funding streams

• the usefulness of EU-level actions

• possible shortcomings of the Plan

• priorities for the next phase of the Plan

Contributions, including evaluations, best practices, and lessons learned, will help inform future EU cancer policies.

🗓 Deadline for feedback: 15 February

🔗 Survey link: https://www.surveymonkey.com/r/ZYZZLJP

As part of the SAMIRA action plan in support of implementing Council Directive 2013/59/Euratom and improving radiation safety for Europe’s patients, the results of the 2-year MARLIN study yield a final report of guidelines and recommendations for reporting and learning from patient-related incidents and near misses in radiotherapy, interventional cardiology, nuclear medicine, and interventional and diagnostic radiology. Now published in the European Commission’s Radiation Protection Series, the report reiterates the mandate to monitor the use ionising radiation in the diagnosis and treatment of diseases, report and investigate incidents and near misses, and disseminate the lessons learned, which are then utilized in staff training and safety measures. The incident learning system can be a comprehensive tool for reporting incidents, gathering evidence, analysing data and disseminating lessons, but their use varies across Europe. In one aspect, they can be administered by clinical facilities, competent authorities and professional societies, and some may contribute to international systems such as the IAEA’s Safety in Radiation Oncology (SAFRON) or ESTRO’s Radiation Oncology Safety Education Information System (ROSEIS).

The consortium led by EIBIR and containing experts also from EFOMP and ESTRO surveyed clinical facilities, competent authorities and professional societies to understand the advantages and disadvantages of systems in operation and best practices for implementing and maintaining them, leading to the formulation of consensus guidelines and recommendations, which were refined and adapted following consultation with competent authorities and European professional organisations in addition to a workshop held just before the end of the project. Professional societies, competent authorities, patient representatives and independent clinical experts comprised the project’s Advisory Board, which also provided vital guidance during the course of the study.

The final report explores additional topics such as particularities for each clinical field, protection of reporters, criteria for reporting, classification of incidents, just culture, disclosure and patient relations. Moreover, the benefits of collaboration among clinical facilities, competent authorities and professional societies are detailed, adding to a comprehensive perspective in this practice. The document should ease the implementation and maintenance of incident learning systems, a key component in ensuring the safe and quality use of ionising radiation in medicine and better outcomes in diagnosis and treatment for patients.

👉 Read the final report of the MARLIN study

On the occasion of World Cancer Day, Marie-Pierre Revel, ESR 2nd Vice-President and leader of the regional lung cancer screening (LCS) pilot on female recruitment within the SOLACE project, was featured in a documentary broadcast by TV5MONDE titled “Neither Tobacco nor Cancer: The Fight of a Lifetime.”

The documentary highlights the human side of lung cancer screening, focusing on women in France who are smokers or former smokers and who took part in the CASCADE study, a lung cancer screening initiative led by Marie-Pierre Revel. Through personal stories, the film explores the challenges of smoking cessation, the impact of early diagnosis, and the importance of prevention and support in improving patient outcomes.

By showcasing real-life experiences rather than statistics alone, the documentary aims to raise awareness about the value of lung cancer screening and early detection in saving lives.

Marie-Pierre Revel plays a key role in advancing lung cancer prevention and screening efforts across Europe through her leadership within SOLACE, particularly in strengthening female participation in screening programmes. Her contribution also aligns with EIBIR’s mission to support innovative research and collaborative initiatives that improve cancer diagnosis and care.

The documentary was broadcast on 4 February on TV5MONDE in connection with World Cancer Day.

👉 Watch the documentary here